<DOC>
	<DOCNO>NCT00728052</DOCNO>
	<brief_summary>Study investigate safety , tolerability pharmacokinetics GSK598809 otherwise healthy volunteer . This study require drug develop treatment nicotine dependence . It important evaluate drug interacts healthy smoker . The study plan consist single part , 4 dosing period . Subjects receive 3 escalate dos GSK598809 1 dose placebo . There least 1 week wash dos . In dose period 14 subject receive escalate dos 4 subject receive placebo . The actual dos use determine base safety/ tolerability pharmacokinetics previous dose . It expect duration study approximately 10 week .</brief_summary>
	<brief_title>A Human Volunteer Study Investigating Single Oral Doses GSK598809 Otherwise Healthy Smokers .</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Inclusion : A healthy man woman 18 50 year old Neither fat , thin Female subject must use acceptable method contraception first dose study medication 90 day follow final followup visit . Female subject must breast feed breast feed month . Male subject must agree use acceptable method contraception first dose study medication 90 day follow final followup . Subjects need smoke 20 40 cigarette day inclusive least past year try quit 3 month start study . Exclusion : Any current medical psychiatric illness Any history chronic medical psychiatric illness Previous current alcohol drug abuse/dependence include nicotine Personal family history prolong QTc syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>single</keyword>
	<keyword>Tolerability</keyword>
	<keyword>dose escalation</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>GSK598809</keyword>
	<keyword>placebo</keyword>
	<keyword>Safety</keyword>
	<keyword>Smokers</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>